Diet‐derived antioxidants do not decrease risk of ischemic stroke: A Mendelian randomization study in 1 million people
Journal of the American Heart Association Nov 25, 2021
Martens LG, Luo J, van Dijk KW, et al. - In this study, no evidence was found for a causal link between dietary‐derived antioxidant levels and ischemic stroke. Hence, antioxidant supplementation is unlikely to be clinically beneficial to avert ischemic stroke.
The links between genetically influenced antioxidant levels in blood and ischemic stroke were assessed using Mendelian randomization in this study.
Independent genetic instrumental variables were selected for each circulating antioxidant (vitamins E and C, lycopene, β‐carotene, and retinol), and summary statistics for single‐nucleotide polymorphisms–stroke links were used from 3 European‐ancestry cohorts (cases/controls).
None of the genetically influenced absolute antioxidants or antioxidant metabolite levels were causally related to a lower risk of ischemic stroke, in an integrated sample of 1,058,298 persons (70,791 cases).
The estimated odds ratios (ORs) for absolute antioxidants levels ranged between 0.94 for vitamin C and 1.04 for lycopene.
ORs, for metabolites, ranged between 1.01 for retinol and 1.12 for vitamin E.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries